Copy-Number and Structural Variants

  • Copy-number variants (CNVs) and structural variants (SVs) are important forms of genetic variation that involve changes in the number, size, arrangement, or orientation of DNA segments within a genome. Unlike single-nucleotide variants, which affect individual nucleotide positions, these variants can involve hundreds, thousands, or millions of DNA bases and may affect entire genes, multiple genes, or large regulatory regions. Copy-number and structural variants contribute to genetic diversity, evolution, differences in biological traits, inherited disorders, and cancer. In bioinformatics, their identification and interpretation are essential for understanding genome organization, investigating disease mechanisms, and characterizing genetic variation across individuals and populations.
  • Copy-number variants are genomic changes in which a DNA segment is present in a different number of copies compared with a reference genome or an expected baseline. The major types of CNVs are deletions and duplications. A deletion reduces the number of copies of a genomic region, whereas a duplication increases the number of copies. In a diploid organism, most autosomal regions normally have two copies, one inherited from each parent. A deletion may reduce a region to one copy or, in some cases, remove both copies, while a duplication may produce three or more copies. Copy-number changes can affect a single gene, several neighboring genes, or large chromosome segments. The number of copies of a genomic region can influence gene dosage, which refers to the amount of genetic material available to support gene expression and biological function.
  • Structural variants are a broader category of genomic changes that alter the physical structure or organization of DNA. Common types include deletions, duplications, insertions, inversions, and translocations. Deletions remove DNA segments, while duplications create additional copies of genomic regions. Insertions introduce DNA sequences at new locations, including sequences that may originate from transposable elements or other genomic regions. Inversions occur when a DNA segment is reversed in orientation within a chromosome. Translocations involve the movement or exchange of DNA segments between different genomic locations, sometimes between chromosomes. Structural variants may be balanced, in which the overall amount of DNA remains approximately unchanged, or unbalanced, in which DNA is gained or lost. These categories can overlap because some structural variants, particularly deletions and duplications, also produce copy-number changes.
  • Although the terms are closely related, CNVs and SVs are not identical. Copy-number variation specifically describes changes in the number of copies of genomic regions, whereas structural variation includes changes in genomic organization and may occur without changing copy number. For example, an inversion may reverse a segment’s orientation without increasing or decreasing the amount of DNA. A balanced translocation may relocate genetic material without a net gain or loss, while a deletion generally reduces copy number. A duplication may simultaneously be classified as both a copy-number variant and a structural variant. The precise size thresholds used to distinguish small variants from structural variants vary between studies and analytical methods, although structural variants commonly involve changes of tens to hundreds of bases or more.
  • Copy-number and structural variants can arise through several molecular mechanisms. Errors during DNA replication may cause segments to be duplicated or deleted, particularly in regions containing repeated sequences. Non-allelic homologous recombination occurs when similar DNA sequences at different genomic locations recombine incorrectly, potentially generating deletions, duplications, or inversions. Other mechanisms include non-homologous end joining, which repairs DNA double-strand breaks without requiring extensive sequence similarity; microhomology-mediated repair; replication-based rearrangement mechanisms; and the activity of transposable elements. Chromosome breakage followed by incorrect repair can also produce complex rearrangements involving several genomic regions. The underlying mechanism often influences the size, structure, and sequence characteristics of the resulting variant.
  • The effects of CNVs and SVs depend on their size, genomic location, gene content, and regulatory context. Deletions may remove essential genes or regulatory elements, while duplications can increase gene dosage and alter the balance of biological pathways. Some variants interrupt genes, disrupt coding sequences, or alter splice patterns. Others change the distance between genes and their regulatory elements, move genes into new regulatory environments, or create fusion genes. Structural variants can also affect chromatin organization and three-dimensional genome architecture, influencing interactions between promoters, enhancers, and other regulatory regions. However, not every structural change has a harmful effect; many variants are tolerated and contribute to normal genetic diversity.
  • Copy-number variation is associated with several inherited conditions and developmental disorders. Deletions and duplications can change the dosage of genes involved in development, neurological function, metabolism, and other biological processes. Some conditions are caused by a specific recurrent deletion or duplication, while others result from more complex genomic changes. The effects may depend on whether one or both copies of a gene are affected, whether the variant is inherited or arises spontaneously, and whether other genetic or environmental factors contribute to the phenotype. A CNV that disrupts one gene may have a different consequence from a larger CNV affecting several genes and regulatory elements.
  • Structural variants are also important in cancer genomics. Somatic rearrangements can activate oncogenes, disrupt tumor-suppressor genes, or create fusion genes that contribute to abnormal cell growth. For example, the BCR::ABL1 fusion gene is associated with chronic myeloid leukemia and results from a translocation involving chromosomes 9 and 22. Copy-number amplification can increase the dosage of genes that promote cell proliferation, while deletions may remove genes involved in cell-cycle control or DNA repair. Cancer genomes may contain multiple overlapping copy-number changes and complex rearrangements that arise as tumor cells evolve. Their detection can support tumor classification, research into disease progression, and the identification of potential therapeutic targets.
  • CNVs and SVs also play important roles in evolution, population genetics, and adaptation. Gene duplication can provide additional copies of genes that may later acquire new functions or become specialized for different biological roles. Copy-number differences in genes involved in immunity, sensory perception, metabolism, and environmental responses can contribute to variation among populations and species. Structural variants can influence recombination patterns, genome stability, and the organization of genetic material. Comparing these variants across species or populations helps researchers investigate genome evolution, natural selection, genetic diversity, and relationships among organisms.
  • Bioinformatics is essential for detecting and interpreting copy-number and structural variants because these changes can be difficult to identify from raw sequencing data alone. The analysis may use whole-genome sequencing, whole-exome sequencing, long-read sequencing, microarray data, or other genomic technologies. Each method provides different types of evidence and has different limitations. Whole-genome sequencing can identify variants across coding and noncoding regions, while whole-exome sequencing focuses mainly on protein-coding regions and may miss many structural changes outside the targeted sequences. Chromosomal microarrays can detect many copy-number changes across the genome but generally provide less precise information about the exact DNA breakpoints and orientation of rearranged segments.
  • Short-read sequencing analysis typically begins with quality control and alignment of sequencing reads to a reference genome. Computational tools examine changes in read depth, discordant paired-end alignments, and split reads to identify possible structural variants. Reduced read depth may indicate a deletion, while increased depth can support a duplication. Paired-end reads mapping farther apart than expected, or in an unexpected orientation, can provide evidence of a rearrangement. Split reads that align to separate genomic locations can help identify breakpoints. Combining multiple signals can improve detection, although repetitive regions, low-complexity sequences, and complex genomic structures remain challenging.
  • Several bioinformatics tools are commonly used for CNV and SV analysis. CNVnator and Control-FREEC can detect copy-number changes from sequencing read depth, while tools such as DELLY, Manta, and LUMPY identify structural variants using different combinations of alignment evidence. Long-read sequencing tools such as Sniffles can detect structural variants using longer DNA reads, which often provide better resolution of repetitive regions and complex rearrangements. Other tools support the analysis of copy-number changes from exome data or targeted sequencing. Tool selection depends on the sequencing platform, read length, coverage, reference genome, variant type, and analytical objective. No single method detects every class of structural variant equally well.
  • After candidate variants are identified, annotation and interpretation help determine their potential biological significance. Bioinformatics pipelines can compare variant coordinates with gene annotations, regulatory elements, known genomic regions, and population databases. They may determine whether a deletion removes a gene, whether a duplication changes the number of copies of a coding region, or whether a rearrangement creates a possible gene fusion. Population reference resources and disease-associated variant databases can provide supporting evidence, but their coverage and interpretation may be incomplete. Variant classification therefore requires consideration of genomic content, inheritance, population frequency, clinical findings, and other evidence appropriate to the study.
  • Accurate CNV and SV analysis presents several technical challenges. Short sequencing reads may not uniquely map to repetitive genomic regions, and complex rearrangements can produce multiple possible interpretations. Sequencing coverage varies across the genome, potentially making copy-number estimation difficult. Different computational tools may report the same variant with different breakpoints or representations, complicating comparisons across studies. Reference genomes may also fail to represent some forms of structural diversity present in specific populations. Researchers address these challenges through quality control, comparison of complementary detection methods, standardized variant representation, visual inspection of relevant evidence, and independent validation when necessary. Long-read sequencing and pangenome references are improving the analysis of regions that are difficult to resolve using traditional short-read approaches.
  • Advanced bioinformatics integrates CNV and SV data with single-nucleotide variants, gene expression, epigenomic profiles, proteomics, and clinical information. This integration can reveal how structural changes affect transcription, RNA processing, protein production, and cellular pathways. In cancer research, combining copy-number profiles with gene-expression data can help identify amplified genes associated with tumor growth. In inherited disease research, structural variants can explain genetic conditions that remain unresolved after analysis of small variants alone. Machine learning methods are also being developed to improve variant detection, prioritize potentially damaging changes, and interpret complex genomic patterns, although their results require careful validation and biological context.
  • Copy-number and structural variants are fundamental components of genome variation. They alter the dosage, structure, or arrangement of genetic material and can influence gene function, development, disease susceptibility, cancer progression, and evolutionary adaptation. Bioinformatics provides the computational tools needed to detect these changes, characterize their genomic structure, and investigate their biological significance. By combining sequencing technologies, computational analysis, genomic annotation, and experimental evidence, researchers can gain a more complete understanding of structural diversity and its importance in biology, medicine, agriculture, and population genetics.
Author:

Leave a Reply

Your email address will not be published. Required fields are marked *